EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Green Drug Discovery: Leveraging Biodiversity for Sustainable Pharmaceutical Solutions

Arshdeep Singh, Rabin Debnath, Viney Chawla, Pooja A Chawla iD

Chemistry & Biodiversity · 2026

DOI: 10.1002/cbdv.202500733 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Chemistry & Biodiversity, 2026. Verfasst von Arshdeep Singh und 3 weiteren Autor:innen. Beteiligte Einrichtung: Baba Farid University of Health Sciences, University Institute of Pharmaceutical Sciences and Research, Faridkot, India. Hauptthemen laut MEDLINE: Drug Discovery, Green Chemistry Technology, Biodiversity. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 189 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The pharmaceutical industry is undergoing a crucial transformation toward sustainability, driven by the urgent need to reduce environmental harm while maintaining innovation in drug discovery and development. Next‐generation green pharma integrates biodiversity, green chemistry, biotechnology, and artificial intelligence (AI) to create more eco‐friendly and efficient drug production processes. Nature remains a vast source of bioactive compounds, with plants, microbes, and marine organisms offering promising therapeutic potential. Advances in synthetic biology, CRISPR gene editing and metabolic engineering enable the sustainable synthesis of natural compounds, reducing reliance on resource‐intensive extraction methods. In addition, green chemistry techniques, such as biocatalysis and supercritical fluid extraction, minimize hazardous waste and lower energy consumption. AI and machine learning accelerate drug discovery by efficiently identifying novel compounds, reducing the need for traditional, time‐consuming experimental methods. However, the shift to sustainable pharma faces challenges, including ethical concerns over bioprospecting, conservation efforts, and fair benefit‐sharing of biodiversity resources. As industries and policymakers increasingly focus on sustainability, the pharmaceutical sector is poised to embrace greener practices, ensuring both human health advancements and environmental protection. This paper explores the transformative potential of green pharmaceuticals and their role in shaping a sustainable future for medicine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug DiscoveryGreen Chemistry TechnologyBiodiversityHumansBiological ProductsBiotechnologyArtificial IntelligenceDrug Industry

Stichwörter der Autor:innen

CRISPRGreen Pharmaartificial intelligenceeco‐friendly drug discoverynatural biodiversitysustainability

Substanzen

Biological Products

Autor:innen und Institutionen

  • Baba Farid University of Health Sciences, University Institute of Pharmaceutical Sciences and Research, Faridkot, India.
  • Institute of Pharmacy, Assam Don Bosco University, Tapesia Gardens, Guwahati, India.

ORCID-Profile: Pooja A Chawla

Zitieren

APA

Singh, A., Debnath, R., Chawla, V., & Chawla, P. A. (2026). Green Drug Discovery: Leveraging Biodiversity for Sustainable Pharmaceutical Solutions. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202500733

Vancouver

Singh A, Debnath R, Chawla V, Chawla PA. Green Drug Discovery: Leveraging Biodiversity for Sustainable Pharmaceutical Solutions. Chemistry & Biodiversity. 2026. doi:10.1002/cbdv.202500733

BibTeX
@article{Singh2026,
  author = {Singh, Arshdeep and Debnath, Rabin and Chawla, Viney and Chawla, Pooja A},
  title = {Green Drug Discovery: Leveraging Biodiversity for Sustainable Pharmaceutical Solutions},
  journal = {Chemistry & Biodiversity},
  year = {2026},
  doi = {10.1002/cbdv.202500733}
}
Kostenlos starten →